- Home
- MDAI vs ICCC Comparison
MDAI vs ICCC Comparison
Compare MDAI & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- ICCC
- Stock Information
- Founded
- MDAI 2013
- ICCC 1982
- Country
- MDAI United States
- ICCC United States
- Employees
- MDAI N/A
- ICCC N/A
- Industry
- MDAI Medical/Dental Instruments
- ICCC Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- ICCC Health Care
- Exchange
- MDAI Nasdaq
- ICCC Nasdaq
- Market Cap
- MDAI 51.5M
- ICCC 60.1M
- IPO Year
- MDAI N/A
- ICCC 1987
- Fundamental
- Price
- MDAI $2.52
- ICCC $6.61
- Analyst Decision
- MDAI Strong Buy
- ICCC
- Analyst Count
- MDAI 2
- ICCC 0
- Target Price
- MDAI $4.75
- ICCC N/A
- AVG Volume (30 Days)
- MDAI 762.2K
- ICCC 44.1K
- Earning Date
- MDAI 08-11-2025
- ICCC 08-14-2025
- Dividend Yield
- MDAI N/A
- ICCC N/A
- EPS Growth
- MDAI N/A
- ICCC N/A
- EPS
- MDAI N/A
- ICCC N/A
- Revenue
- MDAI $29,962,000.00
- ICCC $27,302,766.00
- Revenue This Year
- MDAI N/A
- ICCC N/A
- Revenue Next Year
- MDAI $15.15
- ICCC N/A
- P/E Ratio
- MDAI N/A
- ICCC N/A
- Revenue Growth
- MDAI 55.21
- ICCC 28.29
- 52 Week Low
- MDAI $0.82
- ICCC $3.34
- 52 Week High
- MDAI $3.25
- ICCC $7.60
- Technical
- Relative Strength Index (RSI)
- MDAI 54.88
- ICCC 52.55
- Support Level
- MDAI $2.63
- ICCC $6.26
- Resistance Level
- MDAI $2.95
- ICCC $6.80
- Average True Range (ATR)
- MDAI 0.23
- ICCC 0.31
- MACD
- MDAI -0.04
- ICCC -0.03
- Stochastic Oscillator
- MDAI 38.38
- ICCC 50.63
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.